BRCA and Beyond: The Contribution of Genetics to Gynecological Cancer

19th Annual NPWH Premier Women's Healthcare Conference

0.8 CE (NCC Code 3)

Kate McReynolds, APRN, MSc, MSN, ANP-BC, AGN-BC

This presentation will highlight the advances in genetic testing used for risk assessment as well as guiding therapeutic management. The focus will be on BRCA1/2 and other newly discovered genes associated with hereditary gynecological cancer, and on Lynch syndrome. Guidance on interpreting genetic test results will be given.